Skip to main content

  • Health Care Professionals

  • Patients

  • EnglishEnglish
    • CanadaCanada > English
    • CanadaCanada > French

  • Sunovion Pharmaceuticals Inc. logo.

  • Product Innovation

    • Product Innovation

    • Pipeline

    • Psychiatry

    • Neurology

    • Additional Therapies

    • Scientific Publications

  • Careers

    • Careers

    • Job Search

    • Benefits

    • Career Growth

  • Partnerships

    • Partnerships

    • Submission Process

  • Responsibility

    • Responsibility

    • Building Communities

    • Advocating for Patients

  • About Us

    • About Us

    • Mission, Vision & Values

    • People & Culture

    • Executive Leadership

    • Diversity & Inclusion

    • Contact Us

  • News & Media

    • News & Media

    • Media Kit

  • Health Care Professionals

  • Patients

ENGLISH
US
ENGLISH
EUROPE
ENGLISH
CANADA
ENGLISH FRENCH
GLOBAL
ENGLISH
  • Home
  • Who We Are
    • Who We are overview
    • Our Mission, Vision & Values
    • Executive Leadership
      • Nobuhiko Tamura
      • Greg Bokar
      • Matthew D'Ambrosio
      • David Frawley
      • Stephen Freeman
      • Robert Gregorio
      • Antony Loebel
    • Our History
    • Our People
      • Jeffrey Akin
      • Robin Cruz
      • John Gallo
      • Katrina Iserman
      • Henry McMillan
      • Daniel Yi
  • Join Us
    • Join us overview
    • Benefits
    • Job Search
    • Special Programs
    • General Warning to Job Seekers
  • Responsibility
    • Responsibility overview
    • Patient Support & Advocacy
    • Community Building
  • Our Therapies
    • Oor Therapies Overview
    • Aptiom® (eslicarbazepine acetate) tablets
    • Brovana® (aformoterol tartrate) Inhalation Solution
    • Latuda® (lurasidone HCi) tablets
    • Lonhala® Magnair® (glycopyrrolate) Inhalation Solution
    • Lunesta® (eszopiclone) tablets
    • Xopenex® HFA (levalbuterol tartrate) Inhalation Aerosol
  • Research & Development
    • Research & Development overview
    • Our Pipeline
    • Psychiatric Disorders Overview
    • Neurological Disorders Overview
    • Respiratory Disorders Overview
    • Research Grants
    • Disclosure of Clinical Study Data
  • Explore Partnerships
    • Explore Partnerships Overview
    • Our Partners
    • Partnering Contact Form
  • Featured News
  • Health Care Professionals
  • Our Patients
  • Media
  • Contact Us

Follow us on:

  • Featured News Overview
    • Press Releases

Featured News

All press releases

Media

Search Sunovion Newsroom Learn More in Our Media Kit Contact Sunovion

Our Mission, Vision & Values

Learn about Sunovion’s mission, vision and values Responsibility at Sunovion

Our History

Discover more about Sunovion's history Executive Leadership
Page Sources

Email Alerts

Be the first to know the latest news about all things Sunovion

Click here to sign up for and manage email alerts
Email Alerts image
Sunovion Logo
    • Product Innovation
    • Careers
    • Partnerships
    • Responsibility
    • About Us
    • News & Media
    • Patient Support
    • SunovionSupport.com
    • HCP Support
    • SunovionProFile.com
    • SunovionMedical.com
    • Resources
    • Procurement
    • SunovionIISGrants.com
    • SunovionIMEGrants.com
    • Sumitomo Dainippon Pharma

    • Contact Us

  • Terms of Use
  • Privacy Policy & Cookie Notice
  • Medical Disclaimer
  • Social Media Community Guidelines
  • Sources
  • Sitemap
  • Corporate Transparency Documents

SUNOVION, Sunovion logo, and LATUDA are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd.

LUNESTA, Lunesta logo , XOPENEX HFA, and BROVANA are registered trademarks of Sunovion Pharmaceuticals Inc.

APTIOM is a registered trademark of Bial logo , used under license.

LONHALA and Lonhala Magnair logo are registered trademarks of Sunovion Pharmaceuticals Inc. MAGNAIR is a registered trademark of PARI Pharma GmbH, used under license.

eFlow and eLete are registered trademarks of PARI Pharma GmbH.

KYNMOBI and Kynmobi logo are registered trademarks of Sunovion Pharmaceuticals Inc.

© 2021 Sunovion Pharmaceuticals Inc. All rights reserved.

Powered By Q4 Inc. 5.83.0.2 (opens in new window)